Lisata Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$20,840,000 over the previous period. Total operating expenses were $25,708,000.
Profit Margin
| 2014 | 17.93M | -54.87M | -305.89% |
|---|---|---|---|
| 2015 | 22.48M | -80.88M | -359.69% |
| 2016 | 35.28M | -32.65M | -92.55% |
| 2017 | 0 | 22.97M | |
| 2018 | 0 | -16.16M | |
| 2019 | 0 | -20.10M | |
| 2020 | 0 | -8.14M | |
| 2021 | 0 | -27.46M | |
| 2022 | 121.37M | -54.22M | -44.68% |
| 2023 | 0 | -20.84M |
LSTA Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 121.37M | 0 | 0 | 0 | 0 | 0 | 35.28M | 22.48M | 17.93M |
Cost of revenue | 189K | 57.60M | 55K | 63K | 65K | 225K | 372K | 31.13M | 20.15M | 15.67M |
Gross profit | -189K | 63.77M | -55K | -63K | -65K | -225K | -372K | 4.14M | 2.32M | 2.26M |
Operating exp. | ||||||||||
Research and development | 12.73M | 43.46M | 17.68M | 9.25M | 10.79M | 7.59M | 15.84M | 15.10M | 23.89M | 29.19M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20.36M | 0 | 0 |
Total operating expenses | 25.70M | 57.60M | 29.05M | 19.14M | 20.09M | 16.98M | 27.59M | 35.48M | 53.90M | 60.00M |
Operating income | -25.70M | -57.60M | -29.05M | -19.14M | -20.09M | -16.98M | -27.59M | -31.33M | -113.84M | -57.74M |
Other income (expenses), net | 2.53M | 897K | 76K | 132K | 740K | 824K | -104.70K | 21.95K | 15.59M | 2.17M |
Income before tax | -23.17M | -56.70M | -28.97M | -19.01M | -19.35M | -16.16M | -27.69M | -33.17M | -98.25M | -55.57M |
Income tax expense | -2.33M | -2.47M | -1.50M | -10.87M | 749K | -1K | -11.52M | 138.03K | -17.24M | -104.20K |
Net income | -20.84M | -54.22M | -27.46M | -8.14M | -20.10M | -16.16M | 22.97M | -32.65M | -80.88M | -54.87M |
Earnings per share | ||||||||||
Basic EPS | -2.58 | -10.47 | -7.45 | -7.91 | -29.2 | -25.03 | 38.43 | -74.81 | -250.12 | -251.28 |
Diluted EPS | -2.58 | -10.47 | -7.45 | -7.91 | -29.2 | -25.03 | 38.43 | -74.81 | -250.12 | -251.28 |
| Data source |